Impact of Group Medical Visits for Adult Patients with Type 2 Diabetes Mellitus by Pye, Theresa
UNF Digital Commons
UNF Graduate Theses and Dissertations Student Scholarship
2011
Impact of Group Medical Visits for Adult Patients
with Type 2 Diabetes Mellitus
Theresa Pye
University of North Florida
This Doctoral Project is brought to you for free and open access by the
Student Scholarship at UNF Digital Commons. It has been accepted for
inclusion in UNF Graduate Theses and Dissertations by an authorized
administrator of UNF Digital Commons. For more information, please
contact Digital Projects.
© 2011 All Rights Reserved
Suggested Citation
Pye, Theresa, "Impact of Group Medical Visits for Adult Patients with Type 2 Diabetes Mellitus" (2011). UNF Graduate Theses and
Dissertations. 378.
https://digitalcommons.unf.edu/etd/378
 
 
IMPACT OF GROUP MEDICAL VISITS FOR ADULT PATIENTS 
WITH TYPE 2 DIABETES MELLITUS 
 
 
 
By 
Theresa Pye 
 
 
This project submitted to the School of Nursing in partial fulfillment of the requirements 
for the degree of 
 
Doctor of Nursing Practice 
UNIVERSITY OF NORTH FLORIDA 
BROOKS COLLEGE OF HEALTH 
April 2011 
Signature Deleted
Signature Deleted
Signature Deleted
Signature Deleted
Signature Deleted
Signature Deleted
iii 
 
Table of Contents 
List of Tables ..................................................................................................................... v 
List of Figures ..................................................................................................................  vi 
Abstract ...........................................................................................................................  vii 
Chapter One: Introduction ................................................................................................. 1 
Purpose ................................................................................................................... 2 
Definition of Terms ................................................................................................ 3 
Chapter Two: Review of the Literature ..............................................................................5  
Diabetes ...................................................................................................................5  
Behavior Change ...................................................................................................10  
Group Medical Visits ............................................................................................12  
Search for the Evidence ........................................................................................14  
Efficacy of Group Medical Visits for Persons with Type 2 Diabetes ...................15  
Chapter Three: Methodology ............................................................................................19  
Study Design .........................................................................................................19  
Setting ...................................................................................................................19  
Sample ...................................................................................................................20  
Procedures .............................................................................................................20 
Group Medical Visit Intervention .........................................................................21  
Evaluation Plan .....................................................................................................22  
Data Analysis ........................................................................................................25  
Protection of Human Subjects ..............................................................................26  
Chapter Four: Data Analysis .............................................................................................27  
Implementation .....................................................................................................27 
Demographics .......................................................................................................30 
Data Collection .....................................................................................................32  
Hemoglobin A1C ..................................................................................................32  
Diabetes Self Management ....................................................................................34 
Cost Reimbursement .............................................................................................37 
 
Chapter Five: Discussion ..................................................................................................40 
Discussion .............................................................................................................40  
Limitations ............................................................................................................41 
iv 
 
Implications for Future Practice ............................................................................44 
Recommendations .................................................................................................45 
Conclusion ............................................................................................................47 
Appendices ........................................................................................................................49  
Sample Letter to Potential Participants .................................................................49  
Group Medical Visit Information Packet ..............................................................50 
Assessment Data ....................................................................................................54 
Group Medical Visit Agenda .................................................................................55 
Patient Report Card................................................................................................56 
Diabetes Self Management Survey........................................................................57 
Informed Consent...................................................................................................59 
Consent to Attend Group Medical Visits...............................................................63 
Confidentiality Statement .....................................................................................64 
  
References .........................................................................................................................65  
Vita ....................................................................................................................................72  
 
v 
 
List of Tables 
Table 2.1: Diabetes Complications by System ...................................................................7 
Table 2.2: Prevalence Rates for Comorbid Complications .................................................8 
Table 2.3: General Recommendations for Type 2 Diabetes ..............................................11  
Table 2.4: Characteristics of Three Models of Group Medical Visits ...............................15 
Table 3.1: Characteristics of Validity and Reliability for Stanford Scales........................24  
Table 4.1: Monthly Attendance .........................................................................................31 
Table 4.2: Baseline Demographics ....................................................................................31 
Table 4.3: Mean Baseline to Completion Measurements ..................................................32 
Table 4.4: Hgb A1C...........................................................................................................33 
Table 4.5: Paired Samples Test for Self Management.......................................................34 
Table 4.6: Exercise Type / Times a Week .........................................................................35 
Table 4.7: Communication with Provider..........................................................................36 
Table 4.8: Self Efficacy .....................................................................................................36 
Table 4.9: Has Meter / Number of Days Checked Blood Glucose Past Week..................37 
Table 4.10: Cost / Reimbursement.....................................................................................38 
vi 
 
List of Figures 
Figure 4.1: Individual paired comparison of Hgb A1C ....................................................33  
vii 
 
Abstract 
 Diabetes is a condition that is primarily self-managed and lifestyle modifications 
such as diet, exercise, and weight management are necessary to reduce morbidity and 
mortality. Motivation to implement lifestyle modifications through self management is an 
integral part of disease management and studies have shown group medical visits are 
more effective than individual appointments in this patient population.  
The purpose of this project was to develop, implement and evaluate an evidence-
based group medical visit program for up to a maximum of 8 adult patients with type 2 
diabetes in a family practice setting for six months. Seven participants with abnormal 
A1C results accepted the invitation to attend group medical visits.  Here surrounded by 
peers with the same diagnosis, they were able to learn and discuss methods to self 
manage their type 2 diabetes.  
At the conclusion post survey results indicate positive change in some lifestyle 
behaviors and improvement with hemoglobin A1C.  However there was no improvement 
in weight management.  A cost analysis reveals group medical visits may generate a 
small profit when compared to individual visits.  Group medical visits may offer an 
effective means to motivate patients to make lifestyle change to reduce risk. 
 
 
 
 
 
 
Chapter One: Introduction 
The number of patients diagnosed with diabetes is climbing at an alarming rate 
and is considered to be epidemic by some experts. The Centers for Disease Control 
(CDC, 2008) estimated the prevalence rate for diabetes in the United States at nearly 24 
million or 8 percent of the population. This figure is up from the 2002 estimates of 18.1 
million or 6.3% of the population. At first glance this increase may not seem so alarming 
but the overall incidence of type 2 diabetes tripled from 1980 to 2006 with greater than 
one third of the patients being 65 years or older (CDC, 2007a).  
Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases and 
approximately one-third of patients are unaware they even have the disease. The National 
Diabetes Information Clearinghouse (NDIC, 2005) estimates that approximately 54 
million individuals have a pre-diabetic condition (impaired glucose tolerance or impaired 
fasting glucose) that if left untreated will likely develop into diabetes within 10 years.  
 Health care costs associated with diabetes are quite significant. Medical 
expenditures for diabetic patients are 2.3 times greater than non diabetics (American 
Diabetes Association [ADA], 2007). The ADA (2007) estimated expenditures of $174 
billion in 2007, of which $116 billion was spent on direct medical care. Hospitalizations 
for diabetes related problems totaled 24.3 million days with $58.3 billion spent. 
Outpatient care rates were the highest for diabetic patients and totaled $9.9 billion. There 
were 15 million work absences and 120 million reduced performance workdays. 
Approximately 107 million work days lost due to disability attributed to diabetes related 
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complications with 445,000 cases of permanent disability, a 32% increase or $42 billion 
since 2002 (ADA, 2007). 
 Management of chronic conditions involves significant provider time with 
education and counseling as well as time for pharmacological management (De Vries, 
Darling-Fisher, Thompson, & Belanger-Shugart, 2008).  Diabetes is a disease that is 
primarily self-managed. Generally, patients should be seen 3 to 4 times a year and the 
health care provider has limited time during traditional medical visits for patient 
education. Motivation to implement lifestyle modifications through self management 
education is an integral part of disease management to optimize glycemic control and 
minimize complications (ADA, 2009). Group medical visits are an alternative care 
delivery format that may improve outcomes in patients with chronic conditions (De Vries 
et al., 2008). Group medical visits are a combination of three types of visit: individual, 
education and support (Jaber, Braksmajer, & Trilling, 2005). Patients are given ample 
time and opportunity with the provider and are surrounded by peers who are coping with 
the same disease and many of the same issues. Listening to others who have the same 
disease and problems that are empathetic and supportive can be the best change agent 
(Powell, 2007). 
 Purpose 
 The purpose of this project was to develop, implement and evaluate an evidence-
based group medical visit program for up to a maximum of 8 adult patients with type 2 
diabetes in a family practice office for six months. Specifically, outcomes related to 
behavior changes and clinical improvements were evaluated at baseline, 3 and 6 months 
3 
after participation in group medical visits. Additionally cost of providing group medical 
visits in private primary care practice was computed.  
Definition of Terms 
 Diabetes self-management.  For the purposes of this project, diabetes self-
management was defined as the cornerstone behaviors necessary for improved health 
outcomes (Funnell et al., 2009).  Diabetes self-management outcomes were measured 
using five survey scales from the Stanford Patient Education Research Center (2008). 
Scales selected for this project were eating breakfast, glucose testing, exercise, self 
efficacy for diabetes, and communication with physicians.  
 Behavior change.   Behavior changes are based on the American Association of 
Diabetes Educators (AADE), outcomes standards (Tomky, Cypress, Dang, Maryniuk, & 
Peyrot, 2008). Behavior changes are the adoption of identified activities that will improve 
clinical outcomes and ultimately health status.  Behavioral activities include exercise, 
healthy eating habits, monitoring of blood glucose, and problem-solving.  
 Self efficacy.  Self efficacy is an individual’s belief in their capabilities to 
accomplish a specific task and affects their motivation to succeed (Bandura, 1994).   
 Clinical improvement.  Clinical improvement was measured by a decrease in 
glycated hemoglobin A1C, weight and body mass index (BMI). 
 Time.  The time of the proposed project was six months once participants were 
recruited and group medical visits began.   
 Program cost.  An analysis of program cost was calculated using the amount of 
time and resources for the group medical visit and compared to individual visits. 
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 Patient satisfaction.  Patient satisfaction was defined as the liking and approval 
participants have for their care provider.  It was measured by the patient-provider 
relationship, specifically their confidence in communicating with the provider.  
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Chapter Two: Review of the Literature 
 This chapter will begin with an overview of Type 2 diabetes, its pathophysiology, 
complications, treatment and prognosis. This will be followed by a discussion of the 
concepts of group medical visits. The chapter will conclude with identification and 
evidence related to the use of group medical visits in diabetes management. 
Diabetes 
 Diabetes is a complex, chronic metabolic disorder characterized by elevated blood 
glucose levels resulting from defects in insulin production or action (ADA, 2009; CDC, 
2007b). There are three major classifications of diabetes, type 1 diabetes, type 2 diabetes, 
and gestational diabetes. The focus of this discussion is on type 2 diabetes, the more 
prevalent form of this disease.  
 Type 2 diabetes is an insidious disease that quietly progresses undetected for many 
years as the clinical manifestations are often non specific (Hawkins et al., 2002). 
Frequently the diagnosis is not made until complications appear or the patient is acutely 
ill and seeks treatment (ADA, 2009). Based on established criteria, a diagnosis of 
diabetes is made if a fasting plasma glucose is greater than or equal to 126 mg/dl on two 
occasions; or if during an oral glucose tolerance test with a 75 gram glucose load, a two 
hour post prandial test is greater than or equal to 200 mg/dl; or a casual glucose is greater 
than or equal to 200 mg/dl in a symptomatic patient (ADA, 2009). Criteria to test for pre-
diabetes and diabetes in asymptomatic patients has been established as the length of the 
glycemic burden is a predictor of unfavorable outcomes and management exists to reduce 
the risk of progression and complications of the disease.  
6 
  Pathophysiology. While the precise cause of type 2 diabetes is unknown, there are 
many common risk factors that are linked to its development (Hawkins et al., 2002). The 
most common are obesity and inactivity. Type 2 diabetes is characterized by insulin 
resistance and impaired beta cell function (Cnop et al., 2007). During the early stage, the 
body compensates by increasing insulin secretion. This stage of hyperinsulinemia may 
last for many years before the appearance of hyperglycemia. Next there is impaired 
regulation of hepatic glucose production with both overproduction and overuse of 
glucose. A declining beta cell function will eventually lead to beta cell failure (Maitra & 
Abbas, 2005). 
Complications. Individuals with diabetes have an increased risk of death at a rate 
of two times greater when compared to people without diabetes of similar age (CDC, 
2007b). In 2006, diabetes was the seventh leading cause of death and contributed to 
greater than three times as many additional deaths. It is believed these figures are 
conservative as diabetes is likely to be under reported when patients have multiple 
chronic conditions. The majority of deaths are the results of macrovascular complications 
such as stroke and myocardial infarction (CDC, 2007b). The long term effects of diabetes 
may be devastating since the disease process affects virtually every body system. 
Complications associated with the disease are sobering, life altering and as mentioned 
even life threatening. In a 24 hour period there are 4100 new cases, 810 deaths, 230 limb 
amputations, 120 needing dialysis or transplant and 55 newly blind (Beckley, 2006). It is 
estimated that 57.9% or three of five persons with type 2 diabetes have at least one other 
serious associated medical problem (American Association of Clinical Endocrinologists 
[AACE], 2007) (see Table 2.1). Recently the AACE (2007) has identified prevalence 
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rates of macrovascular and microvascular problems in people with diabetes compared to 
those without the disease (see Table 2.2). 
Table 2.1 
Diabetes Complications by System 
System Affected Complication 
Cardiovascular Heart disease 
Stroke 
Hypertension 
Worsens hyperlipidemia 
Peripheral artery disease 
Eye Blindness / Diabetic retinopathy 
Dental Periodontal diseases 
Gastrointestinal Gastroparesis 
Genital Urinary Diabetic nephropathy / End-stage renal failure 
needing dialysis or transplant 
Urinary incontinence in females 
Erectile dysfunction  in males 
Musculoskeletal Amputations  
Diabetic foot wounds 
Nervous System Peripheral neuropathy 
Complications of Pregnancy Major birth defects 
Spontaneous abortions 
Fetal growth abnormalities  
Fluid & Electrolyte Electrolyte imbalance  
Ketoacidosis 
Other More susceptible to other illnesses 
Associated with worse prognoses 
Premature death 
 From “National Diabetes Fact Sheet, 2007: General Information and National Estimates 
on Diabetes in the United States,” by Centers for Disease Control and Prevention, 2007, 
Copyright 2007 by the U.S. Department of Health and Human Services.  
 
 
 Treatment. The best defense against diabetes is prevention of the disease with 
early life style modifications including diet, exercise, and weight control. The Diabetes 
Prevention Program (Knowler et al. 2002) enrolled 3234 pre-diabetic patients and 
randomly assigned them to one of three interventional groups: intensive program of 
lifestyle modification, standard lifestyle recommendations plus metformin and standard   
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Table 2.2 
 
Prevalence Rates for Comorbid Complications 
Problem Prevalence among 
Diabetics 
Prevalence among 
Non-diabetics 
Macrovascular Problems   
   Myocardial infarction 9.8% 1.8% 
   Coronary artery disease  9.1% 2.1% 
   Congestive heart failure 7.9% 1.1% 
   Stroke 6.6% 1.8% 
Microvascular   
   Chronic kidney problems 27.8% 6.1% 
   Foot problems 22.8% 10% 
   Eye damage 18.9% Not Available 
 From “State of Diabetes Complications in America,” by 
American Association of Clinical Endocrinologists, 2007, 
State of Diabetes Complication in America: A Comprehensive 
Report, p 4.  Copyright 2007 by the American Association of 
Clinical Endocrinologists. 
 
lifestyle recommendations plus placebo.  The intensive program of lifestyle modifications 
consisted of a 7% weight loss, low fat, low calorie diet, 150 minutes of brisk exercise a 
week coupled with some counseling and behavior modification activities. The study was 
stopped a year earlier than expected because of a 58% reduction in the development of 
diabetes with lifestyle changes over a three year period. The combination of lifestyle 
recommendations and metformin resulted in a 31% reduction.  
 Early diagnosis and aggressive treatment are required to minimize complications. 
Treatment of Type 2 diabetes includes lifestyle management. The ADA released their 
revisions and updated evidence based standards in January 2009 (ADA, 2009). 
Management includes medical care from a team approach with the patient assuming a 
dynamic role as diabetes is primarily self managed. All patients need to attend initial 
classes and updates as needed to be self sufficient. Self monitoring of blood glucose and 
A1C measurements should be carried out with the frequency depending on the glycemic 
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control, generally 2 to 4 times a year. Medical nutrition therapy and daily exercise are 
fundamental to the management of diabetes.  
 The ADA (2009) recently addressed comorbid conditions in the prevention and 
management of complications and clearly reaffirmed the need for treatment of 
hypertension, hyperlipidemia and obesity. Also recommended were appropriate uses of 
aspirin, statins, angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor 
blockers (ARB). Other recommendations include smoking cessation, immunizations, 
annual labs and exams. Lastly, hyperglycemia may be treated with a variety of 
pharmacotherapy agents including oral medical and subcutaneous insulin (ADA, 2009). 
 Prognosis. The sequelae of complications can be delayed or prevented by intensive 
glycemic control (Murphy, Chapel, & Clark, 2004). The results of the United Kingdom 
Prospective Diabetes Study, a landmark study, and the largest and longest ever conducted 
on type 2 diabetes, clearly demonstrated that lowering blood glucose levels decreased 
complications (Genuth et al., 2002).  The treatment groups received various 
pharmacotherapies and the control group intervention was diet. The study answered many 
questions regarding diabetes care and contributes to the basis for which the guidelines 
used today are developed (Genuth et al.).  
 Clinical guidelines for adults with diabetes can be found at the National Guideline 
Clearinghouse. Other sources of guidelines are the ADA and AACE. Essentially the 
guidelines are all very similar. One difference is ADA recommends an A1C of < 7%, 
while AACE recommends a goal of <6.5% (Clark, 2005). For fasting blood sugar, the 
ADA recommends 70 to 130mg/dl, while AACE recommends <110mg/dl. For the two 
10 
hour post prandial, the ADA recommends < 180mg/dl and AACE at 140mg/dl.  
Recommendations for diabetes surveillance are listed in Table 2.3.  
Behavior Change 
  Patients present to primary care for management of their chronic conditions. 
Generally they are scheduled in 15 minute blocks of time. Providers ask questions, 
examine and formulate diagnoses. With such limited time advice is given with only the 
most important topics covered and often guidance is skimmed over (Magar, Dabova-
Missova, & Gjerdingen, 2006). When the patient returns for follow up, it is frequently 
noted there has been little to no improvement and patients tend to be labeled as 
noncompliant or not motivated.  
 Even though patients are told they need to modify their lifestyle and know the 
consequences of not following the recommendations, many find it difficult to get started 
or stick with the recommended changes (Haskard-Zolnierek, & Dimatteo, 2009). This 
lack of compliance and adherence to the prescribed plan is often due to a lack of 
motivation. The other problem is in these short visits, patients set goals to lose weight, 
start exercising, or stick to a low fat diet but are not taught how to accomplish this (Riley 
& Marshall, 2010).  
 Chronic conditions such as diabetes are significantly influenced by lifestyle 
behaviors. To effectively change behaviors, the ADA recommends programs using a 
combination of behavioral and psychosocial strategies as having improved outcomes 
(ADA, 2009).  Recognizing the need to provide knowledge and skill training to produce 
change, the American Association of Diabetes Educators (AADE) developed an 
evidence-based framework of seven self care behaviors with measurable clinical  
11 
Table 2.3 
General Recommendations for Type 2 Diabetes 
Guidelines Recommendations 
A1C Monitored 2 – 4 times a year depending on control and 
stability 
Lipids Monitored 2 – 4 times a year depending on control  
Other laboratory testing – 
Renal, Liver, Thyroid,  
Monitored annually or as needed 
SMBG Optimal frequency in unknown, will vary to meet goals 
Exercise Regular activity at least 150minutes / week of moderate 
intensity with some strength resistance exercise 
DSME All should receive with a diabetes certified educator 
Medical nutritional therapy Limit saturated & trans fatty acids, high fiber foods 
Obesity Weight loss, low carbohydrate or low calorie diet up to 
one year 
Smoking None, smoking cessation  
Dilated eye exam Monitored annually  
Podiatry exam Monitored annually 
Dental exam Monitored biannually  
Neuropathy Monitored annually 
Immunizations Kept up to date 
Prevention & management 
of complications 
Risk stratification for cardiovascular disease; monitor 
B/P at each visit and treat if indicated with ACE / ARB; 
treat hyperlipidemia with statins; treat cardiovascular 
risk with aspirin  
From “Standards of Diabetes Care – 2009” by the American Diabetes Association, 2009), 
Diabetes Care, 31, pp. S12-S54. Copyright 2008 by the American Diabetes Association. 
 
improvement indicators for improved health.  The seven behaviors include healthy 
eating, being active, taking medication, monitoring, problem solving, healthy coping and 
reducing risks (Tomky et al., 2008).   
 Motivating patients with chronic conditions presents many challenges for the health 
care provider (Miller, 2005). It is extremely difficult to motivate patients to change a life 
time of undisciplined behaviors and habits to modify and sustain a healthy lifestyle. Diet 
and exercise have been identified as the most difficult to control (Nelson & Tuttle, 2007; 
Sullivan & Joseph, 1998). Asking patients to make multiple changes at once may be 
overwhelming. Selecting one goal and focusing on it encourages adherence and it will 
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have a ripple effect (Powell, 2007). Patients must identify barriers, deal with the 
ambivalence of change and adhere to lifestyle changes that can significantly prolong and 
improve their quality of life (Miller, 2005). 
As health care providers one of our goals should be to develop methods to 
improve patient motivation. In the Clinical Guidelines on the Identification, Evaluation, 
and Treatment of Overweight and Obesity in Adults, the National Institutes of Health 
(1998) states it is the duty of the primary care practitioner to heighten a patient’s 
motivation when such is perceived to be of significant benefit for risk reduction. Maclean 
and Pound (2000) identified patient motivation as a way of explaining the differences in 
outcomes of patients with comparable disease processes. Wilson (2004) found education 
coupled with frequent provider contact leads to continued improvement in gylcemic 
control. 
Group Medical Visits 
 In the mid 1970s pediatrician, Martin Stein designed group medical visits as an 
alternative format for well care visits. Finding these visits time consuming, inefficient 
and repetitive, Dr. Stein liked the idea of providing anticipatory guidance and education 
in the group setting. For greater than twenty years, Dr. Stein successfully led well child 
group medical visits (Anderson, 2006).  
 An early study to compare well child care in group visits with traditional visits 
found group visits to be highly acceptable (Osborn & Wooley, 1981). The study found 
group visits provided more time per patient visit, provided increased explanation to 
parents, had more well-child visits completed, greater satisfaction reported and had less 
advice sought between visits (Osborn & Wooley). As the concept of group medical visits 
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evolved, multiple variations developed. Some originated at the hands of managed care 
and HMOs. Other models came from a desire to improve care in specific areas such as 
with the elderly, chronic disease, or acute care situations. 
 Models of care. One popular model is the cooperative health care clinic (CHCC) 
which was started by John Scott as a research project with the elderly in 1991 and has 
become prototypical for other programs nationally. The CHCC was designed to focus on 
high utilizing patients who have frequent contact with the system (Noffsinger & Scott, 
2000). Scott reportedly found this particular population with multiple medical problems 
had the same lifestyle issues and educational needs and found that by meeting with them 
as a group he was able to answer all their questions and meet individual needs, something 
that could not have been done if they had been seen individually (Cunningham & Blaser, 
2004). The CHCC typically consists of five components: socialization, education, break, 
question & answer, and one-to-one provider-patient time (Noffsinger & Scott).  The 
individual time at the group medical visit is brief; patients with more extensive issues are 
seen in additional individual visits.  
 A newer version of this format, the high risk cohort model (HRCM) focuses on a 
specific chronic disease process such as diabetes or coronary heart disease. It is designed 
for patients of all ages (Masley, Sokoloff, & Hawes, 2000). Both of these types of group 
medical visits offer more consistent continuity of care. Patients are invited to join based 
on predetermined criteria. Generally these visits are scheduled for two to two-and-one-
half hours. Patients are assessed by a nurse, vital signs obtained and any specific point of 
care testing is performed. Like the CHCC, patients in HCRM who need brief individual 
or private evaluation may receive it while others are being checked in. For more in-depth 
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issues a separate appointment must be made. The first few minutes are spent in welcome 
and warm up. Then there is a short educational program, followed by group discussion, 
questions and answers. Visits are on a monthly, bimonthly or quarterly basis (Jaber, 
Braksmajer, & Trilling, 2006b). 
  Another model, the drop-in group medical appointment (DIGMA) was developed 
in 1996 to address access to care issues (Noffsinger & Scott, 2000). This model allows 
for any of the provider’s patients to attend. A variety of problems and issues can be 
addressed. This type of group is more holistic in nature addressing psychological, 
behavioral health and physical medical issues (Noffsinger & Scott, 2000). Even though 
the groups are scheduled, they are dynamic and each visit may have a totally different 
mix of patients. Patients seen generally have complaints of an acute nature or follow up. 
Typically this group lasts about 90 minutes and equally involves both a health care 
provider and psychologist. Similar to the other group medical visits, DIGMAs are not 
meant to completely replace individual appointments, but to supplement them. Table 2.4 
depicts the major characteristics of these models. 
Search for the Evidence 
 An electronic search of multiple databases that included Pub Med, Medline, 
CINAHL, EBSCO host, Ovid and Cochrane Database was enlisted. Search terms 
included group medical visits, group visits, group appointments, shared visits; 
motivation, lifestyle management, self efficacy, behavior change; diabetes. Initially the 
hits recovered descriptive articles on how to get started on setting up group medical 
visits, the advantages and what was needed. Multiple research studies were found and in 
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Table 2.4 
 
Characteristics of Three Models of Group Medical Visits  
Model of Group Medical Care Characteristic  
CHCC DIGMA HRCM 
Patient Population Set Population Mixed Group  Set Population 
Focus Multiple problems, 
high utilizing, 
chronic conditions 
Multiple complaint 
generally worried 
well 
Disease specific 
such as DM, HTN, 
Well Baby, 
Prenatal 
Meeting Monthly Weekly Varies 
Led By Provider Provider & 
Behaviorist 
Provider 
Length 120 minutes 90 minutes 2–2 ½ hours 
Membership Invitation only Open group for any 
of provider’s 
patients 
Invitation only 
CHCC = Cooperative health care clinic 
DIGMA = Drop-in group medical appointment 
HRMC = High risk cohort model  
 
total 48 studies were reviewed. Of this, 23 were specifically related to adult diabetes and 
group medical visits, the additional studies involved group medical visits but with 
different patient populations such as pediatrics, mother-baby or chronic care. There were 
41 descriptive articles on general information for group medical visits. A search for a 
systematic review for group visits found a protocol for a review that remained incomplete 
for a number of years (Epling, et al., 2004) and was withdrawn August 2010. 
Efficacy of Group Medical Visits for Persons with Type 2 Diabetes 
  Group medical visits have been recognized as an innovative way of providing care 
that is patient centered, timely and efficient in our changing health care environment 
(Jaber, Brakemajer, & Trilling, 2006b). In situations when patients do not achieve the 
desired goals of treatment, the ADA (2009) suggests intensification of the medical 
regimen. The ADA recognizes there is not one best form of education or approach and 
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that both group education and more frequent contact with the patient are effective 
(Funnell et al. 2009).  
 Patients who have attended group medical visits have higher levels of satisfaction 
with their care as demonstrated by satisfaction surveys (Beck et al., 1997; Bronson & 
Maxwell, 2004; Campbell & Gosselin, 2007). This is not an unexpected finding as group 
medical visits increase face to face time for patients and their healthcare providers (Beck 
et al., 1997). In addition, meeting times are generally once a month instead of every three 
to four months. At the beginning of group visits there are a few minutes for social 
interaction which is frequently nonexistent in individual appointments and providers are 
unhurried. Patients also benefit from improved interactions, time for more questions and 
clarification of unclear information (Clancy, Yeager, Brown, Magruder, & Huang, 2003). 
Patients receive care while in a relaxed atmosphere and receive support from other 
patients and staff. They are more satisfied with their provider and have increased access 
(Thompson, 2000). These factors may account for the increased level of trust in 
providers. 
Advantages of group medical visits include an improved quality of life for 
patients. In one comparison of patients who participated in group medical visits, they 
were found to have fewer visits to emergency departments, subspecialists and decreased 
hospitalizations (Scott et al., 2004). In a set group, patients developed an installation of 
hope from group dynamics, they learned skill building and as their knowledge level 
increased, patients felt more comfortable in making decisions about their own care 
(Carlson, 2003). Participating in group medical visits empowers patients to make 
informed healthcare decisions (Group Health, 2001). Group support and modeling by 
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peers may also promote self-efficacy (Jaber et al., 2006a). Participants have the 
opportunity to share experiences and success with others, who understand what they are 
going through. Group participants overall perceived better coordinated care and 
community orientation (Clancy, Yeager, Huang, & Magruder, 2007).  
 Patients attending group medical visits exhibited higher adherence to the ADA 
standards of care.  In a study with diabetic patients, 76% of group medical visit 
participants were compliant on nine of ten ADA items compared with 23% of the control 
group (Clancy, Cope, Magruder, Huang & Wolfman, 2003). Group participants were 
more likely to receive influenza and pneumonia vaccinations when compared with those 
in traditional care and multiple studies demonstrate group medical visits are an effective 
alternative to traditional individual appointments (Beck et al, 1997; Clancy, Cope, 
Magruder, Huang, & Wolfman, 2003).  
 An improvement in A1C in participants attending group medical visits was 
demonstrated by Trento et al., (2001, 2002, & 2004).  In all control groups there was an 
increase or worsening of A1C.  Clancy, Yeager, Brown, Magruder, et al, (2003) however 
found minimal differences in A1C measurements between the groups. This may be 
related to the length of the study as Clancy, et al, evaluated the effects of group visits  for 
a shorter period of time, six months; while Trento et al., evaluated the effectiveness over 
two, four and five years respectively. Demographically, participants were very similar.  
 In a five year continuation study, Trento et al., (2004) did a follow up to measure 
diabetes knowledge, ability to problem solve, and perceptions of quality of life. Patients 
in the intervention group perceived a higher quality of life and maintained improved 
hemoglobin A1C, decreased BMI and increased HDL. While patients attending group 
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medical visits have an increase in knowledge and ability to problem solve it does not 
necessarily change behaviors. In a group diabetes medical visit, individual participants 
increased the frequency of self monitoring of blood glucose yet the proportion of patients 
monitoring did not increase (Sadur et al., 1999). 
For health care providers, group medical visits have proven to be very rewarding. 
It has freed up appointment slots improving access for other patients. There is increasing 
evidence that group medical visits are an effective way of managing patients with chronic 
conditions (ADA, 2009). As there is increased pressure on health care providers to be 
more productive, this method may help relieve some of the stress and pressure (Barud, 
Marcy, Armor, Chonlahan, & Beach, 2006). Group medical visits have increased 
productivity as much as 31% a month in some instances (Bronson & Maxwell, 2004). 
There is decreased boredom and burn out.  
 While the advantages out weigh the challenges for group medical visits, several 
issues need to be addressed. While patients and insurance plans need to be billed for 
services, most including Medicare do not have a specific group visit code. Group visits 
may be billed as individual office visits appropriate to the level of care provided, not for 
time spent (Bronson & Maxwell 2004). Confidentiality must be addressed with 
participants and agreements should be signed. Another issue that may lead to group 
failure is high drop out rates or low group census. The more often the group visit the 
better the attendance rate (Jaber et al., 2006a). 
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Chapter Three: Methods 
This chapter will include a description of the methods including the design, 
setting, sample and procedures for the study. This will be followed by a discussion of the 
feasibility, data analysis plan and protection of human subjects.  
Study Design 
Using a high risk cohort model, this project allowed up to eight adult patients with 
uncontrolled type 2 diabetes to participate in group medical visits for six months to 
determine if attending group medical visits in place of traditional individual visits 
improves outcomes and reduces cost. The goal was to facilitate self management by 
conducting monthly group medical visits. Patients were enrolled as they responded to 
advertisement of the program and would potentially benefit from more intensive 
management and support than they were currently receiving in individual visits.  
Setting 
 The setting for the study was a family practice office in a large city in the 
Southeastern United States. The office was staffed with two board certified family 
medicine physicians, however one left during the time of this project. There were 
approximately 4000 patients in this practice, approximately 5% of whom have type 2 
diabetes.   Patient payer mix is primarily through private insurance with approximately 
10% self pay.  This office setting was selected to conduct the project at the invitation of 
the physician medical director / owner of the practice.  While attending a local program 
on group medical visits, the physician expressed an interest in conducting group medical 
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visits but was not at a point to begin.  She offered her office and any assistance so this 
project could be accomplished.   
 The intended population for this project was adult patients with uncontrolled type 
2 diabetes.  The designated meeting area was a private conference room with a large table 
and surrounding chairs. The room had a separate entrance and restroom from the rest of 
the medical office practice,  
Sample 
 Eight adult patients with uncontrolled type 2 diabetes diagnosed for at least six 
months were recruited for this project. Uncontrolled diabetes was defined as having an 
A1C >7.5%. Patients who were terminally ill, immobile, had mental or memory 
problems, were severely hearing impaired, or who were non English speaking were 
excluded. Patients were not excluded based on pharmacotherapy for diabetes (oral 
diabetes medication(s) and/or basal insulin) or for comorbid conditions. 
Procedures 
To advertise the practice change, letters and posted signs were made available in 
the waiting room and exam rooms. A list of current patients with the appropriate 
diagnosis code was generated to help identify potential candidates.  Letters were sent out 
to all potential participants inviting them to attend approximately one month before the 
first scheduled group visit (see Appendix A). The identification of potential participants 
and recruitment was conducted by the physician providers in the office who invited the 
patients to attend. The day prior to the visit, patients were called by the office staff to 
confirm and remind them of the appointment. One medical assistant was specifically 
working on this project for consistency. 
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Once a patient agreed to participate by signing a consent form, the chart was 
reviewed by the physician and baseline laboratory testing requested. If there were current 
lab results less than 30 days old, they were used in lieu of obtaining a new set as 
insurance may not pay. Patients were provided with a packet of information that 
explained the concept and the process of group medical visits (see Appendix B).  
Baseline demographic data was obtained from the chart on all patients that 
included date of birth, sex, race, martial status, education completed, type of insurance, 
and occupation. Assessment data was collected at the initial visit and at each subsequent 
visit and included weight, BMI, waist circumference, blood pressure, heart rate, 
respiratory rate, and blood glucose. Laboratory and assessment data was entered into a 
computerized data base by the office staff (see Appendix C for data entry form).  
If the invitation was accepted, the patient switched from individual appointments 
to group medical visits for diabetes care only. Other issues, acute problems and annual 
exams needed to be scheduled as individual appointments.  
Group Medical Visit Intervention 
Group medical visits were scheduled on a monthly basis on the same day and at 
the same time for a six month period. Patients were scheduled to come in 15 minutes 
prior to the designated start time. The first 30 minutes were scheduled for check in which 
consisted of bringing patients back to the check in station; obtaining a full set of vital 
signs, weight, and finger stick blood glucose. One medical assistant was designated to 
assist with the check in. The nurse practitioner completed a brief mental status, 
cardiovascular, respiratory, skin and neurovascular exam in a private exam room. As 
each patient was completed, they returned to the meeting area to wait where magazines 
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and other educational materials were provided. Once everyone was checked in, a brief 
warm up or socialization took place. For the first few visits, the focus was on having 
participants get to know one another. The patient education segment was determined by 
the group. A list of recommended patient education topics were provided to participants. 
Topics included the basics such as physical activity, foot care, lipid management, food 
preparation, or ADA guidelines. After a brief break, discussion questions that referred 
back to the education topic were discussed. As a group, participants were able to decide 
on next month’s topic before leaving (see Appendix D for the agenda and list of 
education topics). At the end of each visit, there was a short amount of time available for 
private consultation or evaluation if needed.  
 At each visit, after data were collected a report card with current medications, 
yearly screening activities, any new laboratory results, and vitals signs from the current 
visit were provided to the patient. Patients were encouraged to review the report and post 
it on an obvious spot such as the refrigerator as a visual cue (see Appendix E).  
Evaluation Plan 
Hemoglobin A1C levels were measured at baseline, at 3 and at 6 months. 
Anthropometric measurements of weight, body mass index (BMI), and waist 
circumference were evaluated at baseline and at monthly visits. A survey of diabetes self-
management was administered at baseline and at 6 months.  
 Hemoglobin A1C. A1C levels were evaluated using the laboratory designated by 
the patient’s individual insurance. As A1C has become the gold standard for assessing 
and monitoring glycemic control, all laboratories determining this value should use 
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method certified by the National Glycohemoglobin Standardization Program (Goldstein 
et al. 2004.  
 Weight.  Weight was measured by using a digital scale with participants removing 
all excess clothing.  
 BMI.  Body mass index was calculated using published charts after obtaining 
weight (NIH, 2008).  
 Waist measurement.  Waist circumference was measured by placing a tape 
measure around the bare abdomen just above each participant’s hip bone. The tape was 
snug but not compressing the skin and will be parallel to the floor. Participants were 
instructed to relax, exhale, and waist measurement was obtained (NIH, 2008).  
 Diabetes self-management. Diabetes related behaviors and self efficacy were 
measured using survey scales from the Stanford Patient Education Research Center  
(2008). This center is well recognized for developing, adapting, and testing self-
administered scales over the past 20 years for chronic disease research. Funding for the 
development of the scales was provided by the National Institute of Nursing Research. 
The scales are free to use for research without permission. Scales selected for this project 
were eating breakfast, glucose testing, exercise, self efficacy for diabetes, communication 
with providers (see Appendix F). 
 Scoring was based on the number circled. If two consecutive numbers are circled, 
the lower number is selected. If the numbers are not consecutive, they are not scored. If 
more than two items are missing, the section is not scored. The self-efficacy and 
communication scales may be summed for a total score. A higher total score indicates 
higher self-efficacy or better communication with providers. These tests have been 
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validated by previous subjects with diabetes (see Table 3.1 for characteristics of validity 
and reliability). 
Table 3.1 
 
Characteristics of Validity and Reliability for Stanford Scales 
Scale Number of 
Items 
Range Internal 
Consistency 
Test-Retest 
Reliability 
Breakfast 
   Ate Breakfast 
   Ate Protein 
 
1 
6 
 
0 – 7 
0 – 1 
 
N/A 
 
N/A 
Glucose 
   Have Machine 
   Days Tested 
 
1 
1 
 
0 – 1 
1 – 7 
 
N/A 
 
N/A 
Exercise  
   Minutes / Week 
   Stretching 
   Aerobic 
 
 
1 
5 
 
 
0 – 180 
0 – 540 
 
 
N/A 
N/A 
 
 
0.56 
0.72 
Self Efficacy 8 1 - 10 0.828 N/A 
Communication 3 0 - 5 0.73 0.89 
From “Self-Management Scales” by the Stanford Patient Education Research Center, 
2008. http://patienteducation.standford.edu/research/  
 
 At the last group medical visit, only three participants were in attendance.  In an 
effort to collect missing post survey data, an amended IRB application was submitted to 
obtain approval to contact the absent participants for data completion.  Once approval 
was obtained, the remaining four participants were contacted and post survey data 
collection was conducted over the phone. 
 Cost/Reimbursement. There are no billing codes for group visits and it is 
unknown if insurance, Medicare or Medicaid will reimburse for the frequency of these 
visits. Documentation and billing for services occurred as usual based on the level of 
complexity and care for each individual and not the time spent in group medical visit. 
Documentation required for billing purposes was met as it included vital signs, past 
medical history, physical exam, and prescribed interventions. If insurers do not pay, the 
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office forgave fees during the course of this project. However this is a medical visit and 
was treated as such. Patients were informed in advance they were expected to make their 
copay as usual at each visit.  
 A cost analysis was completed for group visits for the practice at the completion of 
the project. As routine visits are scheduled at 15 minute intervals a comparison of 
provider time for group medical visits versus individual visits will determine if income 
has been generated to the practice. Results will be dependent on consistent attendance of 
participants.  
Data Analysis 
Data collection was conducted with the assistance of one office medical assistant 
designated for the project. All raw data was checked for errors. Analysis of data was 
computed on SPSS version 16.0 software and a P value of <0.5 was selected to indicate 
statistical significance. For evaluation of internal consistency on the self-efficacy and 
communication scales, Cronbach’s coefficient alpha was used to test reliability. A paired 
sample t-test, pretest – posttest format was used to evaluate the difference between 
individual visits and group medical visits in a comparison of A1C, weight, BMI, and 
waist circumference. A comparison of pre and post self management behaviors (eating 
breakfast, glucose testing, exercise, self efficacy and communication) was evaluated 
using the Wilcoxon rank sum nonparametric test. Due to the small sample size, more 
complex analyses were not able to be performed.   
A descriptive analysis compared group medical visits and individual visits in 
terms of cost and revenue generated.  Costs to the practice included an evaluation of 
personnel time spent in preparation as well as the actual visit.  Anticipated preparation 
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time included call reminders and data collection.   Revenue was evaluated based on the 
coding charges and the amount reimbursed. 
Protection of Human Subjects 
 IRB application was submitted to the University of North Florida IRB and 
approved to conduct this project.  Consent and a pledge to support were also obtained 
from the physician’s office where group medical visits were conducted. Patients were 
provided information and consent forms that explained attendance is voluntary, as is 
sharing of information (see Appendix G). The patient had the option to opt out and return 
to individual visits at any time.  
 Each person was required to sign a confidentiality agreement before and at each 
visit as a reminder. The confidentially statement (see Appendix H) recognizes all medical 
and personal information is confidential and that while they may discuss what was 
learned they should never discuss any information about individual group participants.  
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Chapter Four:  Data Analysis 
This chapter describes the project participants and results.  Hemoglobin A1C as 
well as pre and post self management behaviors (eating breakfast, glucose testing, 
exercise, self efficacy and communication) were longitudinally evaluated.  Descriptive 
statistical analysis was conducted using SPSS version 16 statistical software and a P 
value of < .05 was used to determine significance.   
To identify potential participants for group medical visits a list was generated of 
all patients with type 2 diabetes mellitus and their respective A1C.  The list was reviewed 
and 83 patients were found to have an abnormal A1C.  Invitational letters were sent to 
prospective patients with an A1C>7.5 approximately four weeks prior to the first group 
medical visit.  Replies were received via email and by phone calls within a week of the 
letters going out.  Packets were mailed out to all who expressed an interest and met the 
criteria.  Two days prior to the group medical visit, phone calls were made to remind 
prospective participants of the upcoming visit.  There were additional inquiries from 
other patients after seeing the flyers posted in the office, however none met the criteria. 
Implementation 
This project began with nine patients who attended the first group medical visit.  
After obtaining the initial data and assessment, the visit began with introductions and an 
ice breaker to help participants relax.  A discussion of the purpose and intent of the visits 
helped clarify any misperceptions.  At this visit ground rules and expectations were 
established.   A message board was provided for parking lot items and patients were 
given permission to write their own questions on the board prior to or after each visit.  At 
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the close of each visit, patients were given a homework assignment and at the beginning 
of the next visit it was briefly discussed to reinforce information previously 
given/learned.  In anticipation of the second visit, patients were asked to return with a 
two day meal diary.   
“Eating and Diabetes:  The Food Pyramid” was the topic at the second visit. 
Educational information presented started out with general healthy eating.  Next a 
comparison of the food pyramid was made with the diabetes food pyramid.  Each section 
was discussed in terms of foods in that group and how much should be eaten.  Methods to 
satisfy a sweet tooth and alcoholic drinks were also discussed.  Patients were taught a 
method to estimate a cup (fist), ½ cup (½ fists), and an ounce (cupped hand) and so on.  
Carbohydrate counting was also discussed however it is noted none of the participants 
use this method.  At the close of the visit, participants were provided with work sheets to 
review their own meal plans and see if they were meeting the guidelines and where 
improvement could be made.  A new member joined the group.   
 “Diabetes and Exercise” was the topic of the third group medical visit. The benefits 
of exercise, the best exercise for individuals with diabetes and general exercise guidelines 
were discussed at length.  Various pieces of exercise equipment such as resistance bands 
and hand weights were demonstrated.  Pedometers were provided to those who did not 
have one.  A couple of participants already had one however they were not used in a 
while.  Education was provided on low blood glucose in relationship to exercise and 
when to monitor.  Exercise frequency and cautions were also addressed as well as the 
issue of weather and heat related issues.  Before leaving, “Barriers to Being Active Quiz” 
(CDC, 2005) was given to each participant.     
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At the fourth group medical visit, each participant was provided with a copy of 
their latest lab results from their chart.  Focus was on routine labs such as metabolic 
panel, urine creatinine, hemoglobin A1C and lipids.  Each test was discussed in terms of 
what it was measuring and implications if it was out of range. For some, this was the first 
time they had access to their entire lab results at one visit.  Homework for this visit was 
to review labs and return with any unanswered questions.     
Standards of Medical Care in Diabetes were discussed at the fifth visit and the 
value in meeting the guidelines.  Emphasis was placed on general recommendation for 
patients with type 2 diabetes which included A1C, other lab testing (lipids, renal, liver, 
thyroid), self managed glucose testing, exercise, weight management, smoking, dilated 
eye exam, podiatry exam, dental exam,  immunizations, diabetes self management skills 
and medical nutritional therapy.  For homework patients were encouraged to make 
appointments to complete recommendations if not up to date.  
At the sixth and last visit a review of topics from the previous five visits was 
conducted.  Jeopardy type boards were fixed with the categories and points were 
assigned.  While this last visit was small, all participated and selected categories and 
reviewed questions.  Participants openly discussed things they learned over the course of 
six months of group medical visits.   
During the first visit, participants were generally reserved but during the second 
and subsequent visits they were much more engaged with each other and the topic.  All 
participants expressed interest in learning about their disease and candidly discussed their 
personal experiences and how things affected them.  Many questions were asked and 
although some things were not directly related to diabetes all were pertinent.  Other 
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discussions included hypoglycemia, arthritis, depression, co-morbid conditions, leg 
cramps and family issues.  When some of the topics were discussed, many would nod in 
agreement indicating they had experienced the same thing.  These common bonds helped 
the group become comfortable with one another and open up.   
At the last visit, only a few participants were in attendance.  An amended 
application was resubmitted to the IRB to obtain approval to contact the absent 
participants.  Each was contacted by either myself or the office medical assist in 
collecting the missing survey data. 
Demographics 
Group medical visits were conducted monthly for a period of six months starting 
in April 2010 and ending in September 2010 from 1:30 to 3:30.  Initially, nine patients 
expressed interest in the concept of group medical visits and accepted the invitation to 
attend.  A tenth patient joined the group at the second visit.  Of that group a smaller core 
group (n=7) attended visits regularly thereafter.  Each patient signed the informed 
consent form prior to participation in the group medical visits. All respondents met the 
criteria of uncontrolled type 2 diabetes mellitus (A1C> 7.5%) with an established 
diagnosis for at least six months.  All were on oral diabetes medication and two had 
additional basal insulin in their medication regimen.  All had other comorbid diagnoses 
such as hypertension, hyperlipidemia and coronary artery disease.   
Of the ten enrolled participants, two attended all six group medical visits.  One 
attended five, two attended three, two attended two and three attended one.  Monthly 
attendance is presented in table 4.1.   However, for purposes of this project, data analysis 
was completed on participants who attended two or more group medical visits. 
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Table 4.1 
 
Monthly Attendance 
Month April May June July August September 
Participants 9 5 5 5 6 3 
 
 Participants were between the ages of 51 and 75 with a mean age of 63.6 years.  
The group consisted of three males (42%) and four females (57%).  All participants were 
Caucasian.  Four participants were married; three were widowed, divorced or single.  
Two (28%) participants completed college with one having a bachelor’s degree and the 
other a master’s degree.  The additional 72% completed ‘some’ college.  One participant 
was currently employed and the remaining listed retired or semi-retired as occupation.  
All had a payer source with 57% private insurance and 43% through Medicare. There 
were no significant differences in demographics for those that attended the initial visit but 
did not complete the project.  Demographics for the group were similar to the office 
practice in general. Baseline demographics are presented in table 4.2.   
Table 4.2 
Baseline Demographics  
Participant Age Sex Race Status Education Insurance Occupation 
1 66 M C Single Some College Medicare Semi Retired 
4 65 M C Married Some College BCBS Retired 
5 75 F C Divorced Some College Medicare Retired 
6 70 F C Widowed Some College Medicare Retired 
7 57 M C Married Master’s Humana Retired 
9 61 F C Married Some College BCBS Retired 
10 51 F C Married Bachelor’s BCBS Floral Manager 
 
 During the project interval, no participants had any emergency department visits or 
hospital admissions.  One participant had an additional appointment for a urinary tract 
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infection and another for bronchitis.  None of the participants requested individual 
diabetes appointment during the project. 
Data collection 
 Assessment data collected at each visit included weight, BMI, blood pressure, heart 
rate and respiratory rate.  Random blood glucose was obtained at each visit except one as 
the office ran out of test strips.  Waist circumference was obtained at the initial and the 
last visit instead of at each visit at the request of participants.  Baseline measurements   
obtained at the initial and completion visits are presented in table 4.3.  Each participant 
was provided assessment information obtained at each visit.  Changes were calculated by 
subtracting baseline values from the project completion values.     
Table 4.3 
Mean Baseline to Completion Measurements 
Measurement Initial       Completion Change 
Weight 196.6 197.6 +1 
BMI 30.7 30.9 +0.2 
Waist Circumference 42.6 42.5 -0.1 
Systolic 135 121 -14 
Diastolic 76 62 -14 
Random Blood Glucose 183 154 -29 
Heart Rate 72 71 -1 
Respirations 18 18 No Change 
 
Hemoglobin A1C 
 Baseline hemoglobin A1C values were obtained from the patient’s medical record 
to insure they met the criteria for project inclusion (A1C>7.5).  Participants were 
provided lab slips by the provider to obtain A1C levels at 3 and 6 months.  All 
participants were compliant in having their labs drawn as requested at 3 months and 6 
months with the exception of one participant who left the practice due to a change in 
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insurance.  All participants demonstrated improvement from baseline to three months and 
from baseline to six months excluding the one participant that left the practice whose 
results are unknown.   
Table 4.4 
 
Hgb A1C 
    Participant Baseline        3 months       6 months 
01 7.6 7.0 7.0 
04 7.6 6.3 6.9 
05 10.9 10.2 7.7 
06 7.5 7.5 7.0 
07 7.6 7.6 7.1 
09 7.6 6.7 6.9 
10 16.5 9.6 Left Practice 
 
 
Five out of seven participants (71%) had a lower A1C at 3 months and the other two 
participants showed no change.   Table 4.4 presentsA1C values at baseline, 3 and 6 
months. 
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Figure 4.1. Individal paired comparison of A1C 
 
At six months, all participants had a lower A1C than baseline and 4 out of 6 (57%) met 
the ADA goal of <7%.  Wilcoxon signed rank test shows statistical significance (P = 
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0.031).  Figure 4.1 depicts individual paired comparison of A1C over the six months of 
group medical visits.  The group mean was 9.3 at baseline and decreased to 7.8 and 7.1 at 
three months and six months respectively. 
Diabetes self-management 
Diabetes related behaviors of eating breakfast, glucose testing, exercise, 
communication with provider and self efficacy were measured and scored at baseline and 
at the completion of the project to determine if there was an increase in self management 
behaviors. Overall results from paired t-test for self efficacy, communication with 
provider, exercise and eating breakfast indicate there are no significant differences from 
baseline to end of study.  See Table 4.5 for summary. 
Table 4.5 
 
Paired Samples Test for Self Management 
Paired Differences 
95% Confidence 
Interval of the Difference  
Lower Upper T df 
Sig. (2-
tailed) 
Pair 1 self BL - self EOS  -3.96 1.10 -1.38 6 0.22 
Pair 2 comm BL - comm EOS -0.22 0.41 -1.68 6 0.14 
Pair 3 EX BL - EX EOS -0.87  0.31  -1.18 6 0.28 
Pair 4 Eat BL - Eat EOS -0.22 0.08 -1.19 6 0.28 
self BL =  Self Efficacy at base line            self EOS = Self Efficacy at end of study 
comm. BL = Communication at base line   comm. EOS = Communication at end of study 
EX BL = Exercise at base line          EX EOS = Exercise at end of study 
Eat BL = Ate Breakfast at base line             Eat EOS = Ate Breakfast at end of study 
 
Eating Breakfast.  While statistical significance related to behavior changes was 
not demonstrated, on an individual basis there were some positive changes.  In response 
to the question related to eating breakfast, initially three of seven participants did not eat 
breakfast each day the previous week.  At completion all responded they had eaten  
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breakfast each of the previous seven days.   In addition, the number eating protein for 
breakfast increased.      
Exercise.  Exercise behaviors focused on type of exercise such as stretching, 
strength training or aerobics and amount of total time spent on these activities in the past 
week.  Baseline results reveal three of seven participants did not engage in any exercise 
activity.  At the conclusion of the project all seven reported some exercise even though 
those already exercising did not build on what they were doing.  The time spent in 
exercise was minimal.  Refer to Table 4.6 for summary of exercise type and time. 
Table 4.6 
Exercise Type / Times a Week 
Participant Baseline End of Study 
01 Stretching <30 minutes Walking 30-60 minutes 
04 Stretching <30 minutes; 
Walking >3 hours 
Stretching 30-60 minutes; 
Walking 1-3 hours 
05 None Stretching <30 minutes 
06 None Stretching <30 minutes; 
Walking<30 minutes 
07 None Stretching 30-60 minute;  
Walking 1-3 hours 
09 Bicycling 1-3 hours;  
Walking >3 hours 
Walking 30-60 minutes 
10 Stretching <30 minutes; 
Swimming <30 minutes 
Stretching 30-60 minutes; 
Walking 30-60 minutes 
 
Patient satisfaction.  Survey questions for communication with provider asked if 
participants prepared a list of questions, questioned things not known or understood and 
if personal problems were discussed.  Scoring was based on a 5-point Likert scale  
ranging from ‘never to always’.  Participants either stayed the same or improved except 
for one participant who reported less communication at the end of the project.  See table 
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4.7 for summary.  It is unknown why one participant felt they had less communication 
with their provider.  During the group medical visits all participated and asked many 
questions.   Some would write on the parking lot board and others would bring their 
questions written at home.  All topics were discussed openly and respectfully. 
Table 4.7 
 
Communication with Provider (on Likert Scale 1-5)  
     Participant        Baseline      End of Study          Change 
01 3.4 4.7 +1.3 
04 3.4 4 +0.6 
05 1.3 2.7 +1.4 
06 1.7 5 +3.3 
07 3.4 2 -1.4 
09 4 4   0 
10 3 4 +1 
 
 Self efficacy.   As a means of measuring confidence levels, the self efficacy scale 
focuses on diet, exercise, blood glucose and general care in terms of knowing how to 
manage and when to seek additional support.  Scoring is based on a 10-point Likert scale 
ranging from ‘not at all confident to totally confident’.  At the start, scores reflected 
participants’ feelings of being ‘somewhat confident’.  At completion, five out of 7 (71%) 
participants’ scores suggest an incremental increase in confidence levels.   
Table 4.8 
Self Efficacy (on Likert Scale 1-10)  
    Participant        Baseline      End of Study         Change 
01 7.9 5.5 -2.4 
04 8.8 10 +1.2 
05 3.6 10 +6.4 
06 5.1 6.9 +1.8 
07 5 6 +1 
09 6.8 9.4 +2.6 
10 7.3 6.6 -0.7 
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For the participants with a decrease in their confidence to manage, one was slightly less 
and the other just over 20% less.  For this participant it is unclear why they felt less 
confident because in attending group medical visits their knowledge level would increase 
and in turn their ability to manage and make decisions would increase.    See Table 4.8 
for summary.      
Glucose testing.  At the start of the project, two of the seven participants did not 
own blood glucose meters and only one participant reported testing their blood glucose 
level on a daily basis.  At the conclusion, the two participants still did not have blood 
glucose meters.  Glucometers were offered free of charge several times and both declined 
saying they “would not use them”.  Of the seven participants, three reported checking 
their blood glucose daily, one twice in the past seven days and one only once.   See table 
4.9 for summary.  Two participants had a significant increase in blood glucose self 
monitoring. 
Table 4.9 
Has a Meter/Number of Days Checked Blood Glucose Past Week 
     Participant            Baseline        End of Study 
01 Yes / 2 Yes / 2 
04 No  / 0 No  / 0 
05 Yes / 7 Yes / 7 
06 Yes / 1 Yes / 1 
07 Yes / 0 Yes / 7 
09 No  / 0 No  / 0 
10 Yes / 2 Yes / 7 
 
Cost/Reimbursement 
 
 At the completion of the project, an analysis of cost/reimbursement was conducted 
to determine if this was a financial benefit for the office practice. In evaluating cost, it is 
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noted some things are needed for both group medical visits as well as traditional visits 
such as calling to remind patients of visits, check in procedures and obtaining random  
blood glucose on diabetic patients.  What is different is the assistance of the medical 
assistant during the group medical visit and also the initial steps to prepare for the visits 
by the nurse practitioner.   
 Since this was the first time this type of visits were conducted, prep time was 
considerably longer than if they were ongoing.  Prep time for each month was 
approximately six to eight hours.  Costs were evaluated in terms of time spent preparing 
for the group medical visit, personnel needed and supplies used.   
Table 4.10 
Cost / Reimbursement 
 Initial Cost GMV Traditional 
Posters (2)  $18  
Office Supplies – paper, envelopes $35  
Stamps, mailings $75  
Bottled water, snacks $30  
NP prep time (50 hours) $2250  
MA prep time (3 hours) $45  
Test Strips (free) 0  
Total $2453  
   
Routine Cost   
NP time – 2.5  hours X 6months $675 $675 
MA time – 2.5  hours X 6 months $225 $225 
Total $900 $900 
   
Reimbursement   
Average billing code 99214 99214 
Number of visits from 1:30 – 3:30, April - September  33 X $138 36 X $138 
Total $4,554 $4968 
 
Reimbursement was established by revenues generated by billing codes for patients 
attending group medical visits.  Billing codes were essentially the same as patients 
attending group medical visit met the criteria for a moderate visit code.  This was 
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compared with revenues generated by the number of patients seen individually during the 
same time frame.  Results indicate group medical visits initially will require some upfront 
cost but it is believed that as they are ongoing, they will be equitable and possibly even 
make a small profit when compared to traditionally scheduled patients.  See Table 4.10 
for comparison or cost and reimbursement.  
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Chapter 5: Discussion 
This chapter provides a discussion of the implementation of group medical visits, 
relevant findings, and lessons learned in the process.  Limitations, implications for 
practice and recommendations for future practice are also discussed.   
Discussion 
With an estimated 1.9 million adults diagnosed with diabetes in 2010 the 
incidence is at an all time high (CDC, 2011).  Less than fifty percent of patients fail to 
meet ADA recommended goals (AACE, 2009).  With the risk of significant 
consequences from poorly controlled disease management, it is vital for healthcare 
providers to find ways to motivate patients to make behavioral changes to effectively self 
manage their diabetes.  In the current economical climate, health care providers are under 
increasing pressure to be more productive.  
The purpose of this project was to develop, implement and evaluate an evidence-
based group medical visit program for six months to determine if this intervention will 
have a positive effect on outcomes related to behavior changes and clinical status.   
Additionally, cost of providing group medical visits in private primary care practice was 
evaluated. In previous studies used to evaluate group medical visits, participants came 
from indigent backgrounds.  This project was conducted in an office setting where the 
majority of patients maintain insurance.    
Results of this project demonstrated improvement in A1C levels for all 
participants.  Significantly 57% were able to meet the ADA goal of 7, at three months 
and 83% at six months.  While all did not meet goal, all reduced their risk of 
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cardiovascular events.  Thirty four percent of participants had significantly more risk as 
their A1Cs were greater than ten.   
Disappointingly self management behaviors while improved did not demonstrate 
significant improvement.  As this sample population was older it is unknown if results 
would have been more significant for a younger patient group who would generally be 
physically more able to exercise or feel they have increased satisfaction as the patient-
provider relationship is more accessible and open to communication with their healthcare 
provider.  Results of this project found while not perfect, group medical visits offer an 
opportunity to bridge the gap that is missing in individually scheduled visits.   
Limitations 
There were limitations to this project that have been identified.   Differences 
between pre and post surveys reveal some incremental positive changes for some patients 
while others did not improve.  In a systematic review, Riley and Marshall (2010)      
identified current group visit methods as unsuccessful in demonstrating consistent 
statistical improvement.  Changes in this patient population may have been more 
significant if the sample size was larger and the project conducted over a longer time 
frame.  One possible reason survey changes were not significant is self report biases.  
However an unexpected change was a decrease in blood pressure.  While blood pressure 
was measured at each visit, it was only discussed in global terms.     
As hypertension is a significant comorbid condition for diabetics, recent group 
medical visits have focused on this metabolic marker.  Both Edelman et al. (2010) and 
Turchin, Goldberg, Shubina, Einbinder, and Conlin (2010) demonstrated the positive 
effect group medical visits had on hypertensive patients.   While guidelines identify the 
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need for consistent follow up, there is a lack of information on optimal time between 
visits.  However in a recent study funded by the Agency for Healthcare Research and 
Quality, Turchin et al. found that for patients with both hypertension and diabetes, shorter 
encounter intervals were associated with an accelerated rate of decrease in blood pressure 
when compared with longer encounter intervals.  For patients seen at one month or less it 
took 1.5 months to normalize while those seen at greater than one month took 12.2 
months to normalize.         
Attendance.  One limitation of this evidence based project was attendance was 
not consistent.  The sample size was small and any missed visit was very obvious.  The 
attendance at the first group medical visit started off strong with nine attending.  As the 
visits progressed, attendance at most was five.  For the last visit only three attended.  
Originally five had confirmed attendance but at the last minute one participant had to 
work and another was going out of town and left a day earlier than expected.  At the first 
visit, all expressed interest in attending.  The group medical visit day and time was 
negotiable yet by consensus it remained the third Thursday, 1:30 – 3:30.   Two 
participants, who were currently employed, felt it would not be a problem in getting off 
work.   At the close of the first visit, two participants said they would not be able to 
attend the following visit due to scheduling conflicts (vacation).     
There were three participants that attended only one visit.  After missing the 
second and third visit, when called to remind them of up coming visits, the absent 
patients were asked if they were going to return and one had a work schedule change and 
was not able to get off, another started a volunteer project and was needed on Thursdays.  
The third patient moved across town and had a transportation issue.  In general, 
43 
attendance at group medical visits has been identified variably.  Barud et al., (2006) 
found attendance rates to be between 40 to 60% for each visit and approximately 50% 
returned for a follow up visit.  In contrast, prepared from previous experience with group 
medical visits, Edelman et al. (2010) was able to gain higher attendance rates by using an 
attendance contract, having a consistent care team and by providing a transportation 
stipend.    
Participants.  This homogeneous group of patients represented the practice 
demographics.  Even though this group consisted of mixed sex there was a lack of 
diversity.  All participants were Caucasian, represented a population that is relatively well 
educated and of middle class which is different than found in literature (Clancy, Cope, 
Magruder, Huang, Salter, et al., 2003; Trento et al., 2004).  The generalization of the 
results may be limited when compared to other more heterogeneous populations.  
Considering the majority of past studies have occurred in teaching hospital settings or 
indigent clinics, it is possible this group did not feel they needed to attend as they have 
many resources including the ability to read, access to on-line information and are able to 
pay for needed services.    
Medication.  During the course of this project, two patients had medication 
adjustments as their glucose and A1C levels were significantly elevated.  By virtue of this 
change in therapy, the group medical visit was not pure in the sense that it was the only 
new intervention making it more difficult to tell if the improvements were from the 
increase in medication or a change in self management behaviors.    In comparison some 
groups adjusted medications as part of the group medical visit (Taveira et al., 2010).       
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Limited resources.  For this project in a single office, the opportunity to have a 
multidisciplinary team was limited.  In many studies, group medical visits have been 
conducted by large centers and university hospital settings where the availability of 
multidisciplinary teams are more likely to occur.  Barud et al., (2006) found it beneficial 
to have clinical pharmacists to assist with education.  In other institutions, medical 
residents and diabetes educators are a part of the care team (Yu & Beresford, 2010).        
Implications for Future Practice  
The implementation of this evidence based project was on a much smaller scale 
than has been identified in the literature.  Even with its shorter time frame and smaller 
attendance rate, the results while mixed are indicative of moving in the right direction.  
While all improved or maintained diabetes control it was disappointing there was no 
weight loss. There are many studies that have demonstrated the positive benefits of group 
medical visits including increased provider access, increased provider and patient 
satisfaction, increased compliance with ADA recommendations and decreased 
emergency department visits (Tsang, Lee, Reddy, & Maskarinec, 2010; Clancy et al., 
2007; Clancy, Cope, Magruder, Huang, & Wolfman, 2003).   Findings from this project 
with this sample size and type provide information that can be used to implement other 
group medical visits. 
In retrospect I found I learned a lot implementing group medical visits.  My initial 
goal was to see if group medical visits were a method to motivate patients to make 
positive changes to improve their health status.  However I think I learned just as much as 
participants.  I spent many hours in preparation of each visit, researching and preparing 
content.  I was concerned I would run out of material and have time left.   Interestingly 
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this never happened as participants were engaged in discussion and had pertinent 
questions.   I found providing this type of visit suited my personality.  I like to teach and 
talk to patients so to have the time to do this and not feel rushed was a win – win for all.  
I had the opportunity to provide information and participants had the benefit of attending 
monthly and each visit was the equivalent of three to four individually scheduled visits.   
Another thing learned from this project was the group composition can be defined 
by the time of day and when it occurs.  For example this group with the exception of one 
was all retired.   Coming in and completing the visit during the early afternoon before 
rush hour traffic started was important to them.  For others working during the day, an 
evening timeframe would have been more of interest and for those with children, maybe 
a Saturday morning would have been their choice.   
In planning for future group medical visits I would like to consider offering them 
on a rotating basis.  For example schedule the visit during the daytime mid week and 
then repeat the same content the following week in the evening or Saturday morning.  
Participants could come to which ever time frame suited them.  I recognize beforehand 
the groups may not be as cohesive however as attendance was a problem, this would offer 
the opportunity to still attend. 
Recommendations  
Diabetes is not a stand alone disease of one person and all people with the disease 
do not live alone.  For patients to successfully self manage, a tremendous amount of 
support is needed particularly from household members and family.  Inviting family and 
or significant others to the group medical visits may be beneficial so all hear the same 
message.  This is particularly true if the patient is not the one purchasing the groceries 
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and preparing the meals.  Patterson and Garwick (1994) identified that major stressful 
events, such as chronic illness, affect the family and not just the individual.  Therefore 
including family or significant others in group medical visits may increase self 
management behaviors. Peer and social support are associated with better health.  
Chlebowy, Hood, and Lajoie (2010), in their study of facilitators and barriers for self-
management of type 2 diabetes, identified both family and peer support as vital to 
success. 
Another tool to provide reinforcement and support is the use of automated 
telephone self-management support (ATSM) systems.  In a recent study comparing the 
use of usual care, group medical visits and ATSM, Schillinger, Handley, Wang, and 
Hammer (2009) found both ATSM and group medical visits were superior to usual care.  
However when compared directly to group medical visits, the ATSM had improved self 
management behaviors.  A disappointing factor was the lack of a difference in A1C 
results. As this study was conducted with a vulnerable patient population, it is suggested 
it be repeated with a different patient population to see if it will have the same success.  
The internet has become ‘the place’ for people seeking healthcare information and 
support services (LaCoursiere, 2001). An added tool would be the addition of a computer 
mediated communication for group medical visit participants.  The purpose would be to 
provide education, continued support, encouragement and motivation between group 
medical visits (Funnell & Anderson, 2003).  White and Dorman (2001) identified online 
groups as a useful adjunct to supplement group meetings.  An electronic message could 
be sent on a regular basis along with a forum where participants would have the 
opportunity to ask questions instead of having to wait for the formal group medical visit.  
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For me personally, offering group medical visits definitely was a positive 
improvement over individually scheduled visits.  I prefer not to be rushed and have the 
time to talk with patients to make sure they understand what goals we are trying to 
accomplish and how we should proceed.  With group medical visits it is much easier to 
get to know your patients.  It offers the opportunity to talk in an unhurried manner and I 
feel that as a nurse practitioner I should know my patients and what is influencing them 
or will motivate them.  In view of today’s reimbursement issues in private practice, it is 
necessary that as healthcare providers we use our time wisely and I firmly believe group 
medical visits offers the time to effectively treat patients. 
Conclusion 
 When I started this project I was not sure what to expect.  I knew what I thought 
should happen but never having attended a group medical visit I was a bit uncertain and 
even nervous.  At the first visit when participants arrived and even though I had talked 
with a few on the phone, all were rather quiet and not even talking to each other.  This 
increased my nervousness.  Then once I started, I forgot about being nervous and I 
remembered why I was there (not just graduation) and things seemed to click and come 
together. At subsequent visits participants were more talkative and I felt like they wanted 
to be there as they would come early and after would linger socializing with one another 
while the room was straightened up.  At the conclusion of the visits, one participant when 
asked if he would again participate in group medical visits, said to call him no matter 
what day or topic and he would be there.  He felt he learned a lot and while he was not 
able to do everything, it was making a difference for him.    
48 
 Not a week goes by without something in the news about the effects of type 2 
diabetes.  This chronic illness requires diligence to self-manage and reduce the enormous 
risk of complications.  While group medical visits offer participants many benefits that 
promote self-management behaviors in a supportive atmosphere there is still need to 
further evaluate this health care delivery method especially in private practice.  Group 
medical visits may offer an opportunity to motivate patients to make necessary behavior 
changes (Antonucci, 2008).  However while promising, Riley and Marshall (2010) noted 
“there is not a recognized best structure for a group visit” (p. 937) and “more research is 
needed to develop comprehensive models that consistently improve glycemic control and 
reduce complications” (p. 943).  At this time compared with individual visits, seeing 
patients in group medical visits is a more efficient manner to deliver care that helps 
promotes self-management behaviors that reduce the risk of complication. 
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Appendix A: Sample Letter to Potential Participants 
Dear________________ 
 You are invited to participate in a new way of providing medical care for six 
months for patients with type 2 diabetes. At this time we are offering group visits instead 
of individual office visits. This program is designed specifically with you in mind.  
 
 Usually when you come into the office, you are ill or have a specific issue we need 
to address. In these short individual visits there is little time to discuss at length how to 
manage your diabetes. We recognize diabetes is primarily a self managed process and we 
want to give you the information and tools to be successful. These group visits will 
replace individual visits unless there are other issues that need to be addressed between 
you and your doctor.  
 
 The program we are talking about is called Group Medical Visits. It is when 
patients with same diagnosis meet together on a regular basis (once a month) with their 
medical provider. Many studies have shown that by participating in group visits, you can 
increase your success in making lifestyle changes. Attached is a sample agenda so you 
can see the flow of the visit. The purpose is to improve your health. In the group we will 
discuss a variety of ways to maintain or improve your heath and make sure you are up to 
date with all of the yearly American Diabetes Association recommendations. 
Occasionally we may even have a guest speaker. This is your opportunity to learn how to 
care for yourself and prevent problems.  
 
 This is a nursing doctoral project looking to recruit patients with type 2 diabetic 
with an A1C >7.5%. Patients who are terminally ill, immobile, have mental or memory 
problems, are severely hearing impaired, or who are non English speaking will be 
excluded. Patients may be taking oral diabetes medication(s) and/or basal insulin. 
Patients with other medical problems may attend. 
 
 The first Group Medical Visit will be held April 22, 2010 from 1:30 – 3:30. If you 
are interested, please call the office and speak with the medical assistant assigned to this 
project to make the appointment. If you have any additional questions or concerns, please 
contact Theresa Pye, principal investigator at  or email at 
  We look forward to hearing from you.  
 
Sincerely 
 
 
Anne Waldron MD 
Theresa Pye ARNP     
Doctoral Student 
University of North Florida 
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Appendix B: Group Medical Visit Information Packet 
 
 
 
FAQS ABOUT GROUP MEDICAL VISITS 
 
 
What are Group Medical Visits? 
Group Medical Visits are a combination of three types of visits: individual, education, 
and support. Patients attending traditional visits are scheduled for a limited time to 
address generally one issue while participants attending Group Medical Visits are 
scheduled for approximately 2½ hours. During this time they will go through the same 
check in process and have a brief private evaluation to monitor progress and receive 
individual information. An education topic will be presented or there may be a guest 
speaker such as a dietician or certified diabetes nurse educator. There will be plenty of 
time for questions and answers as well as time for some socialization with the group.  
 
What are the benefits of attending Group Medical Visits? 
For patients attending Group Medical Visits some of the benefits include they are given 
ample time and opportunity with a medical provider and are surrounded by peers who are 
coping with the same disease and many of the same issues. Studies have found patients 
who attend group medical visits have: 
-  Increased patient satisfaction 
-  Improved control of disease, improved health behaviors, improved labs, weight loss 
-  Improved quality of life, decrease in emergency and subspecialist visits 
-  Improvement in meeting ADA standards such as eye & podiatry exams, immunizations  
How often will they meet? 
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Group Medical Visits will meet monthly on the same day and same time. Monthly 
attendance is encouraged.  
 
What are some of the reasons to consider switching from traditional visits to Group 
Medical Visits? 
-  Access to Provider Increased 
-  Power of Group Support  
-  Patient Satisfaction Increased 
-  Self-Management Promoted  
-  Preventive Issues Addressed 
 
Is there a fee to attend Group Medical Visits? 
Group visits will be billed as individual office visits appropriate to the level of care 
provided, not for time spent.  Your fee will include the usual copay required for 
individual office visits.  If there is a problem meeting this, please speak with the medical 
assistant.   
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GROUP VISIT GROUND RULES 
• Attend meetings and be on time so meetings can start and end on time. 
• Respect each others’ privacy. It is ok to discuss what you have learned in these                
sessions but don’t mention anyone’s name outside this group.  
• Respect each other’s opinions. Be accepting and supportive rather than judgmental. 
• Ask questions if you do not understand. 
• Listen carefully to others. 
• Be an active participant. Also allow everyone to have a chance to speak and / or ask 
questions. 
• No side conversations. Everyone can’t talk at the same time. Please turn off cell 
phones. 
• ___________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________ 
Welcome we are glad you are here today! 
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AGENDA FOR THE FIRST SESSION OF GROUP MEDICAL VISIT 
Welcome / Introductions 
Present Overview / Philosophy of Program 
 Traditional Visits versus Group Visits 
Establish Ground Rules for Group Visits 
 Privacy and Confidentiality Statements 
 Reinforce HIPPA  
Elicit Patients Primary Concerns 
 Establish Topic Calendar 
 Patient Responsibilities 
 Discuss Patient Report Card 
 Next Visit 
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Appendix C: Assessment Data   
     
   Baseline Demographic Data 
  
Participant Number:  
Date:  
Date of birth:  
Sex:  
Race:  
Martial status:  
Highest level of education:  
Type of Insurance:  
Occupation:  
 
 Monthly Data  
 
Variable 1st  Month  2nd Month 3rd Month  4th Month  5th Month 6th Month 
Date       
Weight       
BMI       
Waist        
B/P       
H/R       
R/R       
BG       
HgbA1C       
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Appendix D: Group Medical Visit Agenda 
 
 
Group Medical Visit Agenda 
 
Check In        30 minutes 
Vital Signs / Blood Glucose 
Brief Individual Evaluation 
 
Brief Warm Up / Socialization    15 minutes 
Introductions / Welcome 
 
Patient Education Segment     30 minutes 
Topic of the Month 
 
Break        15 minutes 
 
Discussion / Q & A      30 minutes 
 
Planning / Wrap Up / Closing     15 minutes 
 
Provider Discretionary Time     15 minutes 
 
 
 
 
 
 Potential Topics 
 
Type 2 Diabetes Disease Process and Treatment Options  
 
Diabetes Numbers At-a-Glance / What do the Numbers Mean? 
 
Diet / Healthy Eating for People with Diabetes 
 
Physical Activity / Get Moving 
 
Foot Care / Preventing Diabetes Foot Problems 
 
Managing Complications 
 
ADA Recommendations 
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Appendix E: Patient Report Card  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Appendix F   Patient Survey Scales 
 
Appendix F: Diabetes Self Management Surveys   
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Appendix F: Diabetes Self Management Survey 
 
Eating Breakfast 
1. How many times last week did you eat breakfast when you got up?  
          ____________________ times last week  
 
2. This morning, did you eat any of the following foods for breakfast? (Please check all that 
apply)  milk (½ cup)   cheese   yogurt   eggs   meat, poultry, or fish   beans  
If you ate anything else, please write here: 
_____________________________________________________________________ 
Glucose Testing 
1. Do you have a machine to measure your blood sugar (glucose) level?         Yes          No 
2. On how many days in the last week did you test your blood sugar level? (If you were sick in 
the last week, think of the most recent 7 days when you were NOT sick) _________ days 
Exercise Behaviors 
During the past week, even if it was not a typical week for you, how much total time (for the 
entire week) did you spend on each of the following? (Please circle one number for each 
question.)   
 None Less than 
30 min/wk 
30-60 
min/wk 
1-3 
hrs/wk 
More than 
3 hrs/wk 
Stretching or strengthening exercises 
(range of motion, using weights, etc.) 
 
0 
 
 
1 
 
2 
 
3 
 
4 
Swimming or aquatic exercise  
0 
 
 
1 
 
2 
 
3 
 
4 
Bicycling (including stationary 
exercise bikes) 
 
 
0 
 
 
1 
 
2 
 
3 
 
4 
Other aerobic exercise equipment 
(stairmaster, rowing, skiing machine, 
etc.) 
 
0 
 
 
1 
 
2 
 
3 
 
4 
Other aerobic exercise 
Specify: 
 
0 
 
 
1 
 
2 
 
3 
 
4 
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Communication with Provider 
When you visit your medical provider, how often do you do the following (please circle one 
number for each question):  
 Never Almost 
Never 
Some-
times 
Fairly 
Often 
Very 
Often
Always 
Prepare a list of questions for your provider 0 1 2 3 4 5 
Ask questions about the things you want to 
know and things you don’t understand about 
your treatment 
 
0 
 
1 
 
2 
 
3 
 
4 
 
 
5 
Discuss any personal problems that may be 
related to your illness  
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 Self-Efficacy for Diabetes  
We would like to know how confident you are in doing certain activities. For each of the following 
questions, please choose the number that corresponds to your confidence that you can do the tasks 
regularly at the present time. 
Not At All Confident        Totally Confident 
1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you can eat 
your meals every 4 to 5 hours every day, 
including breakfast every day? 
1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you can follow 
your diet when you have to prepare or share 
food with other people who do not have 
diabetes? 
1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you can choose 
the appropriate foods to eat when you are 
hungry (for example, snacks)?  
1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you can 
exercise 15 to 30 minutes, 4 to 5 times a week? 1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you can do 
something to prevent your blood sugar level 
from dropping when you exercise?  
1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you know what 
to do when your blood sugar level goes higher 
or lower than it should be?  
1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you can judge 
when the changes in your illness mean you 
should visit the doctor?  
1      2      3      4      5      6      7      8      9      10 
How confident do you feel that you can control 
your diabetes so that it does not interfere with 
the things you want to do?  
1      2      3      4      5      6      7      8      9      10 
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Appendix G: Informed Consent 
 
 
 
 
 
 
UNIVERSITY OF NORTH FLORIDA  
 
Human Research Consent Form 
Title: Impact of Group Medical Visits for Adult Patients with Type 2 Diabetes Mellitus 
Investigators: Theresa Pye MSN, ARNP-BC 
Affiliations:  University of North Florida School of Nursing 
Contact Information:  
Approved By Institutional Review Board:       
 
This is an important form. Please read carefully. It tells you what you need to know 
about this research study. If you agree to take part in this study, you need to sign 
this form. Your signature means that you have been told about the study and what 
the risks are. Your signature on this form also means that you want to take part in 
this study. 
 
Your participation in this research is entirely voluntary. Refusal to participate in 
this research will involve no penalty or loss of benefits to which you otherwise are 
entitled.  
 
You may discontinue participation in this research study at any time without 
penalty or loss of benefits you are otherwise entitled to. 
 
 
What is the purpose of this study? As part of my doctoral studies in nursing at the 
University of North Florida I am interested in assisting people with diabetes in the 
management of their disease. The purpose of this project is to see if group medical 
visits for adults with type 2 diabetes improve their ability to manage their diabetes.   
 
How many participants will take part in this study? 
Eight patients at this medical office will participate in this project 
 
 
What will happen in this study? 
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If you agree to participate in this project, you will be receiving your diabetes 
medical care during a group session rather than in an individual visit with your 
provider.  Other medical issues, acute problems and annual exams will not be 
addressed during the group medical visits, but will need to be scheduled as 
individual appointments.  
 
During the six month project period, your regular diabetes care will continue. Each 
visit will consist of check in, a patient education segment, questions and answers, 
and planning for next visit.  
 
When you first begin the group medical visits, your hemoglobin A1C blood level will 
be checked, you will be weighed, have your waist circumference measured and be 
asked to complete a questionnaire about your diabetes self-management activities.  
 
Once a month after that, at each group medical visit, you will be weighed and have 
your waist circumference measured.  
 
Three months into the project. Your hemoglobin A1C blood level will be drawn 
again [at your usual lab.]  
 
At the end of the project, your hemoglobin A1C blood level will be drawn again [at 
your lab] and you will be asked to complete the questionnaire about your diabetes 
self-management activities.  
 
Is there any reason I would not be qualified to participate in the study? 
This project is looking to recruit patients with type 2 diabetic with an A1C >7.5%. 
Patients who are terminally ill, immobile, have mental or memory problems, are severely 
hearing impaired, or who are non English speaking will be eligible. Patients may be 
taking oral diabetes medication(s) and/or basal insulin. Patients with other medical 
problems may attend. 
 
How long will I be in the study? 
The group medical visits will occur once a month for six months. Each group 
medical visit will last approximately 2 ½ hours 
 
Are there reasons I might leave the study early? 
Taking part in this study is your decision. You may decide to stop at any time. You 
should tell the director of the study that you wish to stop. In addition, the director of 
this study may stop you from taking part if it is in your best interest. 
 
What are the risks of the study?   
 There are minimal risks or discomforts related to participating in this project. You 
will receive routine diabetes care. Sometimes people in groups feel a little 
embarrassed at first and fear a loss of privacy, but this embarrassment usually goes 
away quickly. If you are in group care and remain uncomfortable in the group 
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setting, you will be offered the opportunity to withdraw from the group and receive 
individual diabetes care. 
 
Are there benefits to taking part in this study? 
Patients attending group medical visits have been found to have an increased 
knowledge and ability to problem solve regarding diabetes. There is increased 
frequency of self monitoring, and increased adherence of American Diabetes 
Association’s Standards of Care. 
 
What other choices do I have if I do not take part in this study? 
If you choose not to participate in the group medical visits, you will continue with 
individual medical appointments for your diabetes care.  
 
Are there any monetary or other compensation or inducements for my taking part in this 
subject? 
None 
 
Are there any financial costs to me to take part in this study? 
Since the only difference in the care provided through the group medical visits is the 
group itself, there are no additional costs to you for receiving your diabetes care this 
way. Your insurance will be billed as usual for this care. In the event that your 
insurance does not pay for something associated with the project, the medical 
practice will forgo those fees. In either case, you will be responsible for the usual co-
pay.  
 
What are my rights if I take part in this study? 
You do not have to take part in this study; but if you do, you may stop at any time. 
You will be told of important new findings or any changes in the project or 
procedures that may affect you. You do not give up any of your rights by taking 
part in this project .  
 
What about confidentiality? 
 Data from this project may be published or used in publications. However, your 
name and other identifying information will not be sent outside of UNF without 
your written permission. 
 
Explain your method further 
Each person will be required to sign a confidentiality agreement before and at each 
visit as a reminder. The confidentially statement  recognizes all medical and 
personal information is confidential and that while they may discuss what was 
learned they should never discuss any information about individual group 
participants.  
 
Will there be audiotaping or videotaping? If so, will I get to view them before they are 
used? Who will review tapes besides the researchers? Who will have access to the tapes? 
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When will they be destroyed? (Note – If tapes are to be used outside of the research 
project, a separate release form should be obtained.) 
There will be no audiotaping or videotaping during the project. 
 
Who can answer my questions? 
You may talk to Theresa Pye -  Principal Investigator at any time about questions 
and concerns you may have about this study. You may contact Theresa Pye at 
 You may also contact Dr. Doreen Radjenovic, my Faculty 
Advisor at the University of North Florida  
 
You may get further information about UNF policies, the conduct of this project , 
and your rights as a project participant from the Chair of the Institutional Review 
Board, Dr. Katherine Kasten, at  
 
 
I have had an opportunity to have my questions answered. I have been given a copy of 
this form. I agree to take part in this study. I am over 18 years of age.  
 
I am at least 18 years old.    (initials) 
 
I have had the study that I am agreeing to participate in explained to me to my 
satisfaction.  
   (initials) 
 
I have had the opportunity to ask any questions that I may have had regarding this study.  
   (initials) 
 
I agree to participate in Impact of Group Medical Visits for Adult Patients with Type 2 
Diabetes Mellitus being conducted by Theresa Pye        and the University of North 
Florida. 
 
  
__________   _______________________________________ 
Date    Printed Name of Participant 
 
    ________________________________________ 
    Signed Name of Participant 
 
_________   _______________________________________ 
Date    Printed Name of Individual Obtaining Consent 
     
 
________   ______________________________________ 
Date    Signed Name of Individual Obtaining Consent 
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CONSENT TO ATTEND GROUP MEDICAL VISITS 
I, hereby, voluntarily consent to participate in a Diabetes Group Medical Visit in which I 
and other patients may share personal health information, if they wish on a purely 
personal basis during a Group Medical Visit. The information will be used to help 
educate the group about various health topics and which may improve my care. I have 
been provided information on the process and understand this is a medical visit. The 
group visit may replace some of my routine visits but I will still have some individual 
visits.  
The group meeting will consist of discussions of current medical conditions, pertinent 
educational information, and open discussion with other patients on diabetes and other 
subjects of interest to the group. I realize have the option of being seen individually and 
may return to individual visits at any time.  
 
Name _______________________________ Date____________________ 
 
Signature_____________________________ 
 
Witness_______________________________ 
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Appendix H: Confidentiality Statement 
 
GROUP MEDICAL VISIT HIPPA NOTICE 
All patients have the right of privacy and confidentiality regarding their medical record. I 
agree to meet with  Group Medical Visits and understand I must respect the privacy of 
members and therefore while I may discuss what I have learned I must not discuss any 
other patient’s medical information or personal business that I may be privileged to hear. 
At times, members may voluntarily share information that will be used to help educate 
the group on various health topics and which may improve my care.  
It is possible that information discussed may be inadvertently disclosed outside of the 
Group Medical Visit by another member. I have been notified of this risk of potential 
disclosure and I wish to participate in a group medical visit. I realize I have the option of 
being seen individually and may return to individual visits at any time.  
 
Name________________________________ Date____________________ 
 
Signature______________________________ 
 
Witness________________________________ 
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